A DESCRIPTIVE STUDY TO ASSESS THE KNOWLEDGE, ATTITUDE AND UTILIZATION OF HUMAN PAPILLOMA VIRUS[HPV]VACCINE AMONG MOTHERS OF ADOLESCENT GIRLS IN A SELECTED COMMUNITY AREA, BANGALORE

Background of the study: Human Papilloma virus (HPV) is a leading cause of cervical and other cancers, with high-risk strains being responsible for the majority of cases. The HPV vaccine is an effective preventive measure, primarily recommended for adolescent girls (9-16 years) before they become sexually active. Despite its proven effectiveness, the knowledge, attitude and utilization of the vaccine vary significantly across different populations. Mothers play a key role in the decision to vaccinate their daughters, influencing the uptake of the HPV vaccine. Factors such as knowledge of the vaccine, cultural beliefs, safety concerns, and healthcare provider recommendations affect this decision. This descriptive study aims to explore the knowledge, attitude and utilization of the HPV vaccine among mothers of adolescent girls. Understanding these factors will help identify barriers to vaccine uptake and guide interventions to improve vaccination rates and reduce the burden of HPV-related cancers.

• World Health Organization. Human papillomavirus (HPV) and cervical cancer. Geneva: WHO; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
• Centers for Disease Control and Prevention. HPV Vaccine Recommendations. Atlanta:CDC; 2023. Availablefrom: https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html
• Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Quadrivalent vaccine against humanpapillomavirusto prevent anogenitaldiseases. N Engl J Med., 2007; 356(19): 1928–43.
• Bruni L, Saura-Lázaro A, Montoliu A, Brotons M, Alemany L, Diallo MS, et al. HPV vaccination introduction worldwide and WHO recommendations: impactoncervicalcancer prevention. Vaccine, 2022; 40(Suppl 1): A31–A39.
• Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr., 2014; 168(1): 76–82.
• PerkinsRB, Clark JA. What affects humanpapilloma virus vaccine uptake inteenage girls? A review of the literature. J Pediatr Adolesc Gynecol, 2012; 25(2): 100–8.
• LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S, et al. Human papillomavirus vaccine delivery strategies that achieved highcoverage in low- and middle-income countries. Bull World Health Organ, 2011; 89(11): 821–30B.
• Wamai RG, Meskele M, Hussein S, Shibeshi ME, Mwanahamuntu MH. Human papillomavirus (HPV) vaccination in developing countries: challenges, opportunities and strategies. Glob Health Action, 2013; 6: 1–12.
• Arbyn M, Weiderpass E, BruniL, de Sanjose S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2020: a worldwide analysis. Lancet Glob Health, 2021; 9(8):        e1017–e1028.
• Elam-Evans LD, Yankey D, Singleton JA, Sterrett N, Markowitz LE, Williams CL, et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years.
• —United States, 2019. MMWR Morbidity and Mortality Weekly Report, 2020 Aug 21; 69(33): 1109–16.
• Vaccination coverage in adolescents | NCIRS [Internet]. Ncirs.org.au. 2025. Available from: https://ncirs.org.au/annual-immunisation-coverage-report-2023-summary/vaccination-coverage-adolescents
• UK. Human papillomavirus (HPV) vaccination coverage in adolescents in England: 2024 to 2025 [Internet]. GOV. UK. 2026. Available from: https://www.gov.uk/government/statistics/human-papillomavirus-hpv-vaccine-coverage-in-england-2024-to-2025/human-papillomavirus-hpv-vaccination-coverage-in-adolescents-in-england-2024-to-2025
• Health Service Executive, National Immunization Office. Quasi-experimental school-based evaluation of HPV vaccination knowledge and uptake among parents and adolescents in disadvantaged and non-disadvantaged schools, Ireland, 2022–2025. Dublin: HSE; 2025.
• Government of Gujarat, Health Department. HPV vaccination awareness and uptake among school-going adolescents: longitudinal programme-based evaluation, Gujarat, 2021–2024. GujHealthRep. 2024 [cited 2026 May 21]. Available from: https://www.gujhealth.gov.in
• KIMS Healthcare Group. HPV vaccination ware ness and barriers among parents of adolescent girls: retrospective hospital-based study, Kerala, 2024–2025. KIMS Health Rep. 2025 [cited 2026 May21]. Available from: https://www.kimshealthcare.com
• Swaleha Furqan, MondalA, SinghN, SinghM, KapoorR. Knowledge and Awareness of Human Papilloma virus Vaccination in an Urbanized Village in Delhi. Cureus. 2025 May 20.
• PandeyD, VanyaV, Bhagat S, VSB, Shetty J. Awareness and Attitude towards Human Papilloma virus (HPV) Vaccine among Medical Students in a Premier Medical School in India. Wu JT, editor. PLoS ONE., 2012 Jul 31; 7(7): e40619.
• JeraldG, Solomon SG. Impact of health education on cervical cancer and HPV vaccine knowledge in adolescent girls in selected schools in Karnataka-mixed-method [Internet]. 2025. Available from: https://www.researchgate.net/publication/395709048_Impact_of_health_education_on_cervical_cancer_ and_HPV_vaccine_knowledge_in_adolescent_girls_in_selected_schools_in_Karnataka-mixed-method
• Purushothaman S, Gowda V, Venkatakrishna S. Awareness on etiology and preventive measures of cancer cervix among female medical students in Rajarajeswari Medical College, Bengaluru. International Journal Of Community Medicine And Public Health [Internet]. 2026 May 30 [cited 2026 May 31]; 13(6): 2975–80. Available from: https://www.ijcmph.com/index.php/ijcmph/article/view/15608